The Investment Committee may extend the timeline by 30 business days, providing recommendations to ensure timely deployment and ongoing monitoring. Upon receiving reasons for delays, the Committee should assess the root cause before approving any partial or full extension.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.